Zoom News : Jul 25, 2021, 05:45 PM
After the second wave of Coronavirus slowed down, there is talk of reopening of schools. Many states have taken a decision to open schools. However, there are still many parents who are not ready to send their children to school in view of the possible third wave of corona. Parents are not able to have full confidence about the safety of their children from the epidemic.
Actually, a major reason behind this is that there is no vaccine for children's corona virus in the country so far. People above the age of 18 are being vaccinated, but the vaccine for children has not yet come in the market. Because of this people are apprehensive. AIIMS director Dr. Randeep Guleria has also said that schools should be considered in those areas, where the positivity rate of Kovid is less than 5 percent.
Most schools in India have been closed since the first nationwide lockdown in March last year to contain the spread of Kovid-19. Dr. Randeep Guleria said that many children in India have been exposed to the virus and many of them have developed natural immunity. He told that by the month of September, the corona vaccine will be available for children. The initial data from clinical trials on children of Covaccine are very encouraging. In such a situation, we are telling you about those vaccines, which are likely to come in the coming time.Covaccine: News agency ANI quoted Dr. Randeep Guleria, Director of AIIMS, as saying that Bharat Biotech's Covaccine trial is going on on children and the results are expected by September. Randeep Guleria's statement comes at a time when the second dose of Covaccine is likely to be administered to children aged 2-6 years in trials next week. The second dose of Covaccine has already been given to children in the age group of 6-12 years at AIIMS Delhi.
Zydus Cadila: Zydus Cadila has concluded the clinical trial of its DNA-based Kovid-19 vaccine ZyCoV-D for the age group of 12-18 and it may be available in the country soon. On July 15, Satyendra Singh, Under-Secretary, Ministry of Health and Family Welfare, said in an affidavit, "It is submitted that Zydus Cadila, the developer of the DNA vaccine, has successfully concluded its clinical trial for the age group of 12-18 years. " Singh further said that Ahmedabad-based Zydus Cadila's DNA vaccine is under Statutory Permission and may be available for children in the age group of 12-18 years in the near future.
Pfizer: Dr. Randeep Guleria said that if the Pfizer-BioNtech vaccine gets the green signal in India, then that too can be an option for children. American vaccine makers Moderna and Pfizer are pushing for an indemnity clause before supplying their Kovid 19 vaccines to India. However, there is no talk of vaccines for children in India of Moderna and Sputnik-V.
Moderna: The use of Moderna's coronavirus vaccine has been approved in Europe on Friday for children aged 12 to 17 years. The European Medicines Agency (EMA), using Moderna's brand name, said, "The use of the Spikevax vaccine in children 12 to 17 years of age will be the same as for those 18 years of age and older." It has to be seen whether this vaccine comes in India or not and if it does, by when it will be available.
Actually, a major reason behind this is that there is no vaccine for children's corona virus in the country so far. People above the age of 18 are being vaccinated, but the vaccine for children has not yet come in the market. Because of this people are apprehensive. AIIMS director Dr. Randeep Guleria has also said that schools should be considered in those areas, where the positivity rate of Kovid is less than 5 percent.
Most schools in India have been closed since the first nationwide lockdown in March last year to contain the spread of Kovid-19. Dr. Randeep Guleria said that many children in India have been exposed to the virus and many of them have developed natural immunity. He told that by the month of September, the corona vaccine will be available for children. The initial data from clinical trials on children of Covaccine are very encouraging. In such a situation, we are telling you about those vaccines, which are likely to come in the coming time.Covaccine: News agency ANI quoted Dr. Randeep Guleria, Director of AIIMS, as saying that Bharat Biotech's Covaccine trial is going on on children and the results are expected by September. Randeep Guleria's statement comes at a time when the second dose of Covaccine is likely to be administered to children aged 2-6 years in trials next week. The second dose of Covaccine has already been given to children in the age group of 6-12 years at AIIMS Delhi.
Zydus Cadila: Zydus Cadila has concluded the clinical trial of its DNA-based Kovid-19 vaccine ZyCoV-D for the age group of 12-18 and it may be available in the country soon. On July 15, Satyendra Singh, Under-Secretary, Ministry of Health and Family Welfare, said in an affidavit, "It is submitted that Zydus Cadila, the developer of the DNA vaccine, has successfully concluded its clinical trial for the age group of 12-18 years. " Singh further said that Ahmedabad-based Zydus Cadila's DNA vaccine is under Statutory Permission and may be available for children in the age group of 12-18 years in the near future.
Pfizer: Dr. Randeep Guleria said that if the Pfizer-BioNtech vaccine gets the green signal in India, then that too can be an option for children. American vaccine makers Moderna and Pfizer are pushing for an indemnity clause before supplying their Kovid 19 vaccines to India. However, there is no talk of vaccines for children in India of Moderna and Sputnik-V.
Moderna: The use of Moderna's coronavirus vaccine has been approved in Europe on Friday for children aged 12 to 17 years. The European Medicines Agency (EMA), using Moderna's brand name, said, "The use of the Spikevax vaccine in children 12 to 17 years of age will be the same as for those 18 years of age and older." It has to be seen whether this vaccine comes in India or not and if it does, by when it will be available.